Literature DB >> 13032555

Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy.

N E RANKIN.   

Abstract

Entities:  

Keywords:  AGRANULOCYTOSIS; ASPERGILLOSIS/etiology and pathogenesis; CHLORAMPHENICOL/therapeutic use; MONILIASIS/etiology and pathogenesis

Mesh:

Substances:

Year:  1953        PMID: 13032555      PMCID: PMC2016320          DOI: 10.1136/bmj.1.4816.918

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Pulmonary aspergillosis following post-influenzal bronchopneumonia treated with antibiotics.

Authors:  J D ABBOTT; H V J FERNANDO; K GURLING; B W MEADE
Journal:  Br Med J       Date:  1952-03-08

2.  Side-effects of chloramphenicol and aureomycin, with special reference to oral lesions.

Authors:  T TOMASZEWSKI
Journal:  Br Med J       Date:  1951-02-24

3.  Systemic mycosis due to Monilia albicans.

Authors:  J V DUHIG; M MEAD
Journal:  Med J Aust       Date:  1951-02-03       Impact factor: 7.738

  3 in total
  12 in total

1.  PULMONARY ASPERGILLOSIS: A REVIEW AND A DESCRIPTION OF THREE NEW CASES.

Authors:  J N MACARTNEY
Journal:  Thorax       Date:  1964-07       Impact factor: 9.139

2.  Diffuse bronchopulmonary aspergillosis.

Authors:  A O BECH
Journal:  Thorax       Date:  1961-06       Impact factor: 9.139

3.  Furadantin in Proteus bacilluria: preliminary communication.

Authors:  S J HEFFERNAN; P W KIPPAX; W A PAMPLIN
Journal:  J Clin Pathol       Date:  1955-05       Impact factor: 3.411

4.  Survey of the medical mycological literature of Great Britain 1946 to 1956.

Authors:  J WALKER
Journal:  Mycopathol Mycol Appl       Date:  1958-09-29

5.  Oral moniliasis in the newborn and neonatal morbidity.

Authors:  K K KAUL; P M SHAH; J N POHOWALLA
Journal:  Indian J Pediatr       Date:  1960-04       Impact factor: 1.967

6.  A case of aspergillosis treated with nystatin.

Authors:  L K MANNING; L ROBERTSON
Journal:  Br Med J       Date:  1959-02-07

Review 7.  Aspergillus fumigatus and related species.

Authors:  Janyce A Sugui; Kyung J Kwon-Chung; Praveen R Juvvadi; Jean-Paul Latgé; William J Steinbach
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

8.  Tissue reactions to Aspergillus in cases of Hodgkin's disease and leukaemia.

Authors:  N F GOWING; I M HAMLIN
Journal:  J Clin Pathol       Date:  1960-09       Impact factor: 3.411

9.  Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis.

Authors:  Ronen Ben-Ami; Nathaniel D Albert; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

10.  Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatus.

Authors:  Natalie D Fedorova; Nora Khaldi; Vinita S Joardar; Rama Maiti; Paolo Amedeo; Michael J Anderson; Jonathan Crabtree; Joana C Silva; Jonathan H Badger; Ahmed Albarraq; Sam Angiuoli; Howard Bussey; Paul Bowyer; Peter J Cotty; Paul S Dyer; Amy Egan; Kevin Galens; Claire M Fraser-Liggett; Brian J Haas; Jason M Inman; Richard Kent; Sebastien Lemieux; Iran Malavazi; Joshua Orvis; Terry Roemer; Catherine M Ronning; Jaideep P Sundaram; Granger Sutton; Geoff Turner; J Craig Venter; Owen R White; Brett R Whitty; Phil Youngman; Kenneth H Wolfe; Gustavo H Goldman; Jennifer R Wortman; Bo Jiang; David W Denning; William C Nierman
Journal:  PLoS Genet       Date:  2008-04-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.